Subclinical elevations of thyroid-stimulating hormone and assisted reproductive technology outcomes

Konstantinos G. Michalakis, Tolga B. Mesen, Lynae M. Brayboy, Bo Yu, Kevin S. Richter, Michael Levy, Eric Widra, James H. Segars

Research output: Contribution to journalArticle

43 Scopus citations

Abstract

The prevalence of moderately elevated TSH levels consistent with subclinical hypothyroidism (2.5-4.0 μIU/mL) was 23% in a cohort of 1,231 women pursuing assisted reproductive technologies. Preconception elevated levels of TSH were associated with diminished ovarian reserve but were not associated with adverse assisted reproductive technology or pregnancy outcomes.

Original languageEnglish (US)
Pages (from-to)2634-2637
Number of pages4
JournalFertility and sterility
Volume95
Issue number8
DOIs
StatePublished - Jun 30 2011

Keywords

  • ART
  • TSH
  • autoimmunity
  • diminished ovarian reserve
  • subclinical hypothyroidism

ASJC Scopus subject areas

  • Reproductive Medicine
  • Obstetrics and Gynecology

Fingerprint Dive into the research topics of 'Subclinical elevations of thyroid-stimulating hormone and assisted reproductive technology outcomes'. Together they form a unique fingerprint.

  • Cite this

    Michalakis, K. G., Mesen, T. B., Brayboy, L. M., Yu, B., Richter, K. S., Levy, M., Widra, E., & Segars, J. H. (2011). Subclinical elevations of thyroid-stimulating hormone and assisted reproductive technology outcomes. Fertility and sterility, 95(8), 2634-2637. https://doi.org/10.1016/j.fertnstert.2011.02.056